The 'Pfizer boob job' Following COVID Vaccination: Experts Explore Possible Causes

Social Media · January 13

A curious phenomenon has emerged as dozens of British women report noticeable breast enlargement after receiving COVID vaccines. This revelation comes just days after startling images of a 19-year-old Canadian woman showed her breasts quadrupling in size—a reaction experts attribute to the Pfizer vaccine, coining the term 'Pfizer boob job.'

Data from the UK's Medicines and Healthcare products Regulatory Agency (MHRA) reveals 33 cases of breast enlargement linked to the Pfizer vaccine. Additionally, 11 British women reported similar changes after the AstraZeneca jab, while four noted the same reaction following Moderna's vaccine. These instances were documented through the Yellow Card system, which relies on patient reports that have yet to be medically verified.

Experts caution that these unexpected bodily changes might coincidentally align with vaccination, rather than result from it. However, some doctors argue that a plausible link exists. A recent medical report from the University of Toronto delves into a young woman's case, theorizing that an immune response triggered by the vaccine could have led to abnormal cell growth in her breasts.

This report details how the Canadian woman, initially a B cup, experienced a progression to a triple G cup size within six months after two doses of the Pfizer vaccine. The rapid growth began with tingling and slight enlargement post the first dose in September 2022 and accelerated following the second dose.

The condition, known as gigantomastia, is characterized by extreme breast enlargement and is exceedingly rare. Researchers are still investigating the triggers, with some cases linked to hormonal imbalances or specific drug reactions. The Toronto medics suggest the possibility of the vaccine inducing a rare condition called pseudoangiomatous stromal hyperplasia (PASH), where myofibroblasts in breast tissue grow excessively, forming benign lumps. PASH is poorly understood, with only around 200 documented cases and no previous vaccine connections.

Further examinations of the woman revealed slightly swollen lymph nodes and dense blood vessels in the armpit region, attributed to the enlarged breast tissue. Biopsies confirmed PASH as the cause of her breast growth. Despite undergoing steroid and antibiotic treatment, the swelling persisted, prompting her to opt for a breast reduction to return to a DD size 11 months post-vaccination. She later underwent another procedure to correct asymmetry, ultimately reducing her size back to a B cup.

While the temporal association between the vaccine and PASH appears suggestive, the experts emphasize that causality cannot be definitively established without further research. They advocate for additional investigation into the link between COVID-19 vaccines and unusual reactions like PASH and breast hypertrophy. They also criticized healthcare providers who dismissed the patient's concerns, stressing that ignoring such issues could undermine trust in medical relationships.

In a related finding from 2021, researchers at the University of Pennsylvania noted that COVID vaccines could cause swollen lymph nodes in the armpit, potentially leading to abnormal mammogram and ultrasound results. British health authorities have acknowledged this possibility and advised medical staff to investigate any abnormal scan findings as potential breast cancer symptoms rather than dismissing them as vaccine reactions.

Based on a report by Daily Mail 2024-01-14